437 related articles for article (PubMed ID: 9066479)
1. General practitioners' perceptions of the tolerability of antidepressant drugs: a comparison of selective serotonin reuptake inhibitors and tricyclic antidepressants.
Martin RM; Hilton SR; Kerry SM; Richards NM
BMJ; 1997 Mar; 314(7081):646-51. PubMed ID: 9066479
[TBL] [Abstract][Full Text] [Related]
2. WITHDRAWN: Treatment discontinuation with selective serotonin reuptake inhibitors (SSRIs) versus tricyclic antidepressants (TCAs).
Barbui C; Hotopf M; Freemantle N; Boynton J; Churchill R; Eccles MP; Geddes JR; Hardy R; Lewis G; Mason JM
Cochrane Database Syst Rev; 2007 Jul; (3):CD002791. PubMed ID: 17636706
[TBL] [Abstract][Full Text] [Related]
3. Selective serotonin reuptake inhibitors versus tricyclic and heterocyclic antidepressants: comparison of drug adherence.
Barbui C; Hotopf M; Freemantle N; Boynton J; Churchill R; Eccles MP; Geddes JR; Hardy R; Lewis G; Mason JM
Cochrane Database Syst Rev; 2000; (4):CD002791. PubMed ID: 11034764
[TBL] [Abstract][Full Text] [Related]
4. The treatment of depression in UK general practice: selective serotonin reuptake inhibitors and tricyclic antidepressants compared.
Lawrenson RA; Tyrer F; Newson RB; Farmer RD
J Affect Disord; 2000 Aug; 59(2):149-57. PubMed ID: 10837883
[TBL] [Abstract][Full Text] [Related]
5. Treatment discontinuation with selective serotonin reuptake inhibitors compared with tricyclic antidepressants: a meta-analysis.
Anderson IM; Tomenson BM
BMJ; 1995 Jun; 310(6992):1433-8. PubMed ID: 7613276
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and tolerability of selective serotonin reuptake inhibitors compared with tricyclic antidepressants in depression treated in primary care: systematic review and meta-analysis.
MacGillivray S; Arroll B; Hatcher S; Ogston S; Reid I; Sullivan F; Williams B; Crombie I
BMJ; 2003 May; 326(7397):1014. PubMed ID: 12742924
[TBL] [Abstract][Full Text] [Related]
7. Association between mortality from suicide in England and antidepressant prescribing: an ecological study.
Morgan OW; Griffiths C; Majeed A
BMC Public Health; 2004 Dec; 4():63. PubMed ID: 15613234
[TBL] [Abstract][Full Text] [Related]
8. GPs' perceptions of tolerability of selective serotonin reuptake inhibitors and tricyclic antidepressants. Research into long term use is needed.
Bhatti N; Graffy J
BMJ; 1997 Aug; 315(7107):547; author reply 548. PubMed ID: 9329322
[No Abstract] [Full Text] [Related]
9. Amitriptyline for depression.
Guaiana G; Barbui C; Hotopf M
Cochrane Database Syst Rev; 2007 Jul; (3):CD004186. PubMed ID: 17636748
[TBL] [Abstract][Full Text] [Related]
10. Amitriptyline versus other types of pharmacotherapy for depression.
Guaiana G; Barbui C; Hotopf M
Cochrane Database Syst Rev; 2003; (2):CD004186. PubMed ID: 12804503
[TBL] [Abstract][Full Text] [Related]
11. A randomised controlled trial to compare the cost-effectiveness of tricyclic antidepressants, selective serotonin reuptake inhibitors and lofepramine.
Peveler R; Kendrick T; Buxton M; Longworth L; Baldwin D; Moore M; Chatwin J; Goddard J; Thornett A; Smith H; Campbell M; Thompson C
Health Technol Assess; 2005 May; 9(16):1-134, iii. PubMed ID: 15876362
[TBL] [Abstract][Full Text] [Related]
12. Antidepressant use patterns in clinical practices: comparisons among tricyclic antidepressants and selective serotonin reuptake inhibitors.
Donoghue J
Acta Psychiatr Scand Suppl; 2000; 403():57-61. PubMed ID: 11019936
[TBL] [Abstract][Full Text] [Related]
13. GPs' perceptions of tolerability of selective serotonin reuptake inhibitors and tricyclic antidepressants. Clinical assessments are liable to bias.
Grace J
BMJ; 1997 Aug; 315(7107):547; author reply 548. PubMed ID: 9329323
[No Abstract] [Full Text] [Related]
14. Incidence and prevalence of primary care antidepressant prescribing in children and young people in England, 1998-2017: A population-based cohort study.
Jack RH; Hollis C; Coupland C; Morriss R; Knaggs RD; Butler D; Cipriani A; Cortese S; Hippisley-Cox J
PLoS Med; 2020 Jul; 17(7):e1003215. PubMed ID: 32697803
[TBL] [Abstract][Full Text] [Related]
15. Prescribing selective serotonin reuptake inhibitors as strategy for prevention of suicide.
Freemantle N; House A; Song F; Mason JM; Sheldon TA
BMJ; 1994 Jul; 309(6949):249-53. PubMed ID: 7832842
[TBL] [Abstract][Full Text] [Related]
16. Effects of tricyclic antidepressants, selective serotonin reuptake inhibitors, and selective serotonin-norepinephrine reuptake inhibitors on the ocular surface.
Ismayilov AS; Celikel G
Arq Bras Oftalmol; 2022; 86(5):e20230068. PubMed ID: 35544938
[TBL] [Abstract][Full Text] [Related]
17. Antidepressant use and risk of adverse outcomes in older people: population based cohort study.
Coupland C; Dhiman P; Morriss R; Arthur A; Barton G; Hippisley-Cox J
BMJ; 2011 Aug; 343():d4551. PubMed ID: 21810886
[TBL] [Abstract][Full Text] [Related]
18. Orphan comparisons and indirect meta-analysis: a case study on antidepressant efficacy in dysthymia comparing tricyclic antidepressants, selective serotonin reuptake inhibitors, and monoamine oxidase inhibitors by using general linear models.
Ballesteros J
J Clin Psychopharmacol; 2005 Apr; 25(2):127-31. PubMed ID: 15738743
[TBL] [Abstract][Full Text] [Related]
19. Length of therapy with selective serotonin reuptake inhibitors and tricyclic antidepressants in Australia.
McManus P; Mant A; Mitchell P; Dudley J
Aust N Z J Psychiatry; 2004 Jun; 38(6):450-4. PubMed ID: 15209838
[TBL] [Abstract][Full Text] [Related]
20. An examination of the attitudes and practice of general practitioners in the diagnosis and treatment of depression in older people.
Rothera I; Jones R; Gordon C
Int J Geriatr Psychiatry; 2002 Apr; 17(4):354-8. PubMed ID: 11994890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
